The key to establishing a cycle of discovery is establishing a proper, formally structured systematic approach to treatment that aims to understand the reasons for treatment failure.
Microglia may serve a protective purpose for the masses, but for those who suffer from fibromyalgia, these adaptive cells of the central nervous system are the enemy—the source of constant flu-like sickness and pain.
Change comes at a price. While there is little doubt that biologics have changed the landscape of therapy in rheumatic diseases, they have also raised the costs of healthcare in the process.
In the rapidly evolving field of medicine, what may seem esoteric today could be standard of care tomorrow.
The power of technology is driving breakthroughs in medicine with advances in genomics, proteomics, metabolomics, and informatics, to name just a few.
Despite early and aggressive intervention, remission rates remain low for rheumatology patients; damage is often progressive, morbidity and mortality are significant, and socioeconomic decline is an ongoing concern.

Results 1 - 6 of 6
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology